These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 480974)

  • 1. Pharmacokinetics and bioavailability of chlordiazepoxide in humans.
    Krzyśko K; Wichliński LM
    Mater Med Pol; 1979; 11(1):15-8. PubMed ID: 480974
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of two preparations of chlordiazepoxide.
    Smith TC; Moyer CE
    Curr Ther Res Clin Exp; 1976 Aug; 20(2):204-10. PubMed ID: 821721
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacokinetics of chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J; Franke K
    Psychopharmacol Bull; 1975 Oct; 11(4):34-5. PubMed ID: 1105640
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).
    Roberts RK; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1978 Sep; 75(3):479-85. PubMed ID: 680505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of oral and intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM; Franke K; Giles HG
    Eur J Clin Pharmacol; 1978 Jun; 13(4):267-74. PubMed ID: 668784
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses.
    Greenblatt DJ; Shader RI; Franke K; Harmatz JS
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):486-93. PubMed ID: 700911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination.
    Patwardhan RV; Johnson RF; Sinclair AP; Schenker S; Speeg KV
    Gastroenterology; 1981 Sep; 81(3):547-51. PubMed ID: 7250643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxide.
    Whiting B; Lawrence JR; Skellern GG; Meier J
    Br J Clin Pharmacol; 1979 Jan; 7(1):95-100. PubMed ID: 760747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow absorption of intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    N Engl J Med; 1974 Nov; 291(21):1116-8. PubMed ID: 4416981
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptide derivatives as prodrugs.
    Thomas WA
    Biochem Soc Trans; 1986 Apr; 14(2):383-7. PubMed ID: 3709951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics of etoposide (VP-16).
    Smyth RD; Pfeffer M; Scalzo A; Comis RL
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):48-51. PubMed ID: 3975657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of chlordiazepoxide in patients with alcoholic hepatitis.
    Morgan DD; Robinson JD; Mendenhall CL
    Eur J Clin Pharmacol; 1981 Mar; 19(4):279-85. PubMed ID: 7286030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Strazzabosco M; Orlando R; Nassuato G; Iemmolo RM; Lirussi F; Muraca M; Pastorino AM; Castelli G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of smoking on metabolism of chlordiazepoxide.
    Desmond PV; Roberts RK; Wilkinson GR; Schenker S
    N Engl J Med; 1979 Jan; 300(4):199-200. PubMed ID: 759853
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.
    Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Feb; 5(1):25-39. PubMed ID: 845789
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on clinical pharmacokinetics and bioavailability of sodium phenytoin by high performance liquid chromatography (HPLC)].
    Lou YQ; Guo WF; Wang WL; Fu YK
    Yao Xue Xue Bao; 1983 Jul; 18(7):487-90. PubMed ID: 6659949
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic determinants of the response to single doses of chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    Am J Psychiatry; 1974 Dec; 131(12):1395-7. PubMed ID: 4432941
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetics and absolute bioavailability of bromopride from various pharmaceutical formulations].
    Lücker PW; Tinhof W; Wetzelsberger N; Weyers W; Brodbeck R
    Arzneimittelforschung; 1983; 33(3):453-8. PubMed ID: 6683522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioavailability of furosemide in humans].
    Wichliński L; Maruchin J; Wiezowska B
    Acta Pol Pharm; 1978; 35(3):359-63. PubMed ID: 696370
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability and pharmacokinetics of clavulanic acid in healthy subjects.
    Davies BE; Coates PE; Clarke JG; Thawley AR; Sutton JA
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):70-3. PubMed ID: 3872847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.